Taxotere as a cornerstone treatment of NSCLCGIACCONE, Giuseppe.Lung cancer. 2005, Vol 50, issn 0169-5002, 43 p., SUP2Conference Proceedings

Applications of genomics in NSCLCROSELL, Rafael; COBO, Manuel; ISLA, Dolores et al.Lung cancer. 2005, Vol 50, pp S33-S40, issn 0169-5002, SUP2Conference Paper

Optimizing chemotherapy and targeted agent combinations in NSCLCLYNCH, Thomas JR; KIM, Edward.Lung cancer. 2005, Vol 50, pp S25-S32, issn 0169-5002, SUP2Conference Paper

Optimizing chemotherapy for advanced non-small cell lung cancer : focus on docetaxelBELANI, Chandra P.Lung cancer. 2005, Vol 50, pp S3-S8, issn 0169-5002, SUP2Conference Paper

Adjuvant and neoadjuvant chemotherapy in NSCLC : a paradigm shiftBETTICHER, Daniel C.Lung cancer. 2005, Vol 50, pp S9-S16, issn 0169-5002, SUP2Conference Paper

Current perspectives on treatment strategies for locally advanced, unresectable stage III non-small cell lung cancerRIGAS, James R; LARA, Primo N.Lung cancer. 2005, Vol 50, pp S17-S24, issn 0169-5002, SUP2Conference Paper